A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. (Record no. 22638469)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02452 a2200685 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516143208.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201401s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1557-3265 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/1078-0432.CCR-12-3381 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Socinski, Mark A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20140108 |
245 00 - TITLE STATEMENT | |
Title | A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
Date of publication, distribution, etc. | Jun 2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 3068-77 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anaplastic Lymphoma Kinase |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Rearrangement |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HSP90 Heat-Shock Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor Protein-Tyrosine Kinases |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Triazoles |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goldman, Jonathan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | El-Hariry, Iman |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Koczywas, Marianna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vukovic, Vojo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Horn, Leora |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Paschold, Eugene |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Salgia, Ravi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | West, Howard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sequist, Lecia V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bonomi, Philip |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brahmer, Julie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chen, Lin-Chi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sandler, Alan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Belani, Chandra P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Webb, Timothy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Harper, Harry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huberman, Mark |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ramalingam, Suresh |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wong, Kwok-Kin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Teofilovici, Florentina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Guo, Wei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shapiro, Geoffrey I |
773 0# - HOST ITEM ENTRY | |
Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
Related parts | vol. 19 |
-- | no. 11 |
-- | p. 3068-77 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-12-3381">https://doi.org/10.1158/1078-0432.CCR-12-3381</a> |
Public note | Available from publisher's website |
No items available.